Drug profile · INN
candesartan
ATACAND
candesartan (ATACAND) is a type-1 angiotensin ii receptor antagonist. Associated with Alphapharm Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 11
News articles 0
Drug details — candesartan
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 11
- Data quality
- 0.81
Quick answer
candesartan (ATACAND) is a type-1 angiotensin ii receptor antagonist. Associated with Alphapharm Pty Ltd.
Key facts
INN candesartan
Brand ATACAND
Mechanism Type-1 angiotensin II receptor antagonist
Target Type-1 angiotensin II receptor
Originator Alphapharm Pty Ltd
Mechanism of action
Type-1 angiotensin II receptor antagonist
Primary target: Type-1 angiotensin II receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is candesartan?
candesartan (ATACAND) is a type-1 angiotensin ii receptor antagonist. Associated with Alphapharm Pty Ltd.
What is the brand name for candesartan?
ATACAND is a marketed brand name for candesartan. Check FDA Drugs@FDA for the current US label holder and prescribing information.